X-38403663-G-T
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000531.6(OTC):c.586G>T(p.Asp196Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D196V) has been classified as Pathogenic.
Frequency
Consequence
NM_000531.6 missense
Scores
Clinical Significance
Conservation
Publications
- ornithine carbamoyltransferase deficiencyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Laboratory for Molecular Medicine, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| OTC | NM_000531.6 | c.586G>T | p.Asp196Tyr | missense_variant | Exon 6 of 10 | ENST00000039007.5 | NP_000522.3 | |
| OTC | NM_001407092.1 | c.586G>T | p.Asp196Tyr | missense_variant | Exon 8 of 12 | NP_001394021.1 | ||
| OTC | XM_017029556.2 | c.586G>T | p.Asp196Tyr | missense_variant | Exon 6 of 9 | XP_016885045.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Ornithine carbamoyltransferase deficiency Pathogenic:1
This sequence variant is a single nucleotide substitution (G>T) at position 586 of the coding sequence of the OTC gene that results in a aspartic acid to tyrosine amino acid change at residue 196 of the ornithine transcarbamylase protein. This is a previously reported variant (ClinVar 97258) that has been observed in individuals affected by ornithine transcarbamylase deficiency (PMID: 9686344, 17044854). This variant is absent from the gnomAD population database (0/~200,000 alleles). Multiple bioinformatic tools predict that this Asp to Tyr amino acid change would be damaging, and the Asp196 residue at this position is highly conserved across the vertebrate species examined. Studies examining the functiol consequence of this variant have not been performed, to our knowledge; however missense mutation is a common mechanism of disease for OTC, and different variants at this position have been previously considered pathogenic. Based upon the evidence, we consider this variant to be likely pathogenic. ACMG Criteria: PM2, PP2, PP3, PS4
not provided Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at